CHICAGO (MedPage Today) -- A new MRI contrast agent, gadobutrol, was well-tolerated and safe according to results in more than 15,000 patients, researchers said here. via MedPageToday.com - medical news plus CME for physicians Read More Here..
Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/12/gadobutrol-deemed-safe-in-early-analysis.html
No comments:
Post a Comment